Publication|Videos|February 13, 2025
Implementing Diversity, Equity, and Inclusion in Drug Development
Jennifer Kim, PhD, assistant research professor, Tufts School of Medicine, Tufts Center for the Study of Drug Development, discusses barriers to participation for underrepresented populations in clinical trials and how Tufts is conducting research to better understand their nature.
Advertisement
Episodes in this series
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Business Case for DEI in Pharmaceutical Innovation: Why Organizational Commitment Matters for Inclusive Clinical Trials
2
Women as the Missing Voice in Parkinson’s Disease
3
Applying AI to Reduce Administrative Burden Without Losing the Human Touch
4
Why Startup Timelines Are Worsening—and How to Reverse the Trend
5